Class 4 caution in use- Clarithromycin 250mg and 500mg

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use- Clarithromycin 250mg and 500mg

Strandhaven Limited t/a Somex Pharma has informed the MHRA regarding an error with the Patient Information Leaflets (PILs) that have been packed in the listed batches of Clarithromycin 250mg and 500mg film-coated tablets.

MHRA drug alert date: 6th December 2023

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-strandhaven-ltd-t-slash-a-somex-pharma-clarithromycin-250mg-and-500mg-film-coated-tablets-el-23-a-slash-42

Pip code	Product	Supplier	Affected Batches
1178425	CLARITHROMYCIN TAB 250MG ACC	SOMEX/STRANDHAVEN	SEE ABOVE LINK
1148766	CLARITHROMYCIN TAB 250MG ALM	SOMEX/STRANDHAVEN	SEE ABOVE LINK
1178433	CLARITHROMYCIN TAB 500MG ACC	SOMEX/STRANDHAVEN	SEE ABOVE LINK
1148774	CLARITHROMYCIN TAB 500MG ALM	SOMEX/STRANDHAVEN	SEE ABOVE LINK
8112807	OTCD CLARITHROMYCIN TAB 250MG	SOMEX/STRANDHAVEN	SEE ABOVE LINK
8082463	OTCD CLARITHROMYCIN TAB 500MG	SOMEX/STRANDHAVEN	SEE ABOVE LINK

This is a caution in use only we are not accepting stock returns

Further Information

For more information, medical information queries, contact: regulatory@somexpharma.com, tel: 020 8590 9399, choose option 3 or 4.

For stock control queries, contact: accounts@somexpharma.com, tel: 020 8590 9399, choose option 2.